Register for real-time alerts, custom portfolio, and market movers

Get Started

ABBV

AbbVie (ABBV)

AbbVie Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

Date	Time	Source	Headline	Symbol	Company
05/12/2023	5:00PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/10/2023	5:11PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
05/09/2023	5:06PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2023	5:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2023	5:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2023	5:04PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
05/09/2023	5:02PM	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NYSE:ABBV	AbbVie Inc
05/09/2023	7:01AM	PR Newswire (Canada)	AbbVie reçoit l'approbation de Santé Canada pour l'emploi de RINVOQ® (upadacitinib) dans le traitement des adultes atteints de spondylarthrite axiale non radiographique évolutive	NYSE:ABBV	AbbVie Inc
05/09/2023	7:01AM	PR Newswire (Canada)	Health Canada Approves AbbVie's RINVOQ® (upadacitinib) for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis (nr-axSpA)	NYSE:ABBV	AbbVie Inc
05/06/2023	7:30AM	PR Newswire (US)	AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®	NYSE:ABBV	AbbVie Inc
05/05/2023	12:59PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:ABBV	AbbVie Inc
05/04/2023	8:09AM	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	NYSE:ABBV	AbbVie Inc
05/02/2023	8:00AM	PR Newswire (US)	AbbVie to Present at the Bank of America Securities Healthcare Conference	NYSE:ABBV	AbbVie Inc
04/27/2023	5:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/27/2023	10:46AM	Dow Jones News	AbbVie Down Nearly 7%, on Track for Largest Percent Decrease Since September 2021 -- Data Talk	NYSE:ABBV	AbbVie Inc
04/27/2023	7:37AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:ABBV	AbbVie Inc
04/27/2023	7:32AM	PR Newswire (US)	AbbVie Reports First-Quarter 2023 Financial Results	NYSE:ABBV	AbbVie Inc
04/25/2023	4:17PM	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NYSE:ABBV	AbbVie Inc
04/21/2023	12:01AM	PR Newswire (US)	AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant (QULIPTA®) for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting	NYSE:ABBV	AbbVie Inc
04/19/2023	5:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/18/2023	10:04AM	PR Newswire (US)	Allergan Aesthetics Celebrates the Journeys of Women Surgeons with LIMITLESS	NYSE:ABBV	AbbVie Inc
04/17/2023	7:41PM	PR Newswire (US)	U.S. FDA Approves QULIPTA® (atogepant) for Adults With Chronic Migraine	NYSE:ABBV	AbbVie Inc
04/17/2023	5:44PM	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NYSE:ABBV	AbbVie Inc
04/17/2023	8:01AM	PR Newswire (Canada)	AbbVie Announces Provincial Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia in Québec	NYSE:ABBV	AbbVie Inc
04/17/2023	8:01AM	PR Newswire (Canada)	AbbVie annonce le remboursement provincial, au Québec, de VRAYLAR® (cariprazine) pour le traitement de la schizophrénie	NYSE:ABBV	AbbVie Inc
04/17/2023	2:00AM	PR Newswire (US)	AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Moderately to Severely Active Crohn's Disease	NYSE:ABBV	AbbVie Inc
04/12/2023	11:00AM	PR Newswire (US)	AbbVie Invites College Students Living with Cystic Fibrosis to Apply for the AbbVie CF Scholarship for the 2023-2024 Academic School Year	NYSE:ABBV	AbbVie Inc
04/11/2023	12:35PM	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	NYSE:ABBV	AbbVie Inc
04/05/2023	5:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc
04/05/2023	5:01PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:ABBV	AbbVie Inc

Showing the most relevant articles for your search:NYSE:ABBV

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

Marketing Worldwide (PK)

Seafarer Exploration (PK)

Bell Buckle (PK)

Canopus Biopharma (PK)

NioCorp Developments

Therapeutic Solutions (PK)

Brookmount Explorations (PK)

Seven Arts Entertainment (PK)

Fannie Mae (QB)

Virexit Technologies (PK)

Kraig Biocraft Laborator... (QB)

Decentral Life (PK)

Ubiquitech Software (PK)

Delayed Upgrade Clock